The Safety and Efficacy of Entecavir and Tenofovir Combination Therapy for Chronic Hepatitis B in Patients with Previous Nucleos(t)ide Treatment Failure

被引:0
|
作者
Jablkowski, Maciej S. [1 ]
Diculescu, Mircea [2 ]
Janssen, Harry L. [3 ,4 ]
Zoulim, Fabien [5 ]
Petersen, Joerg [6 ]
Marcellin, Patrick [7 ,8 ]
Bendahmane, Soumaya [9 ]
Klauck, Isabelle [10 ]
Simon, Krzysztof [11 ]
机构
[1] Med Univ Lodz, Dept Infect & Liver Dis, Lodz, Poland
[2] Fundeni Clin Inst, Ctr Gastroenterol & Hepatol, Bucharest, Romania
[3] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[4] Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada
[5] Lyon Univ, Hosp Civils Lyon, Hepatol Dept, INSERM,U1052, Lyon, France
[6] Asklepios Klin St Georg, IFI Inst Interdisciplinary Med, Hamburg, Germany
[7] Univ Paris 07, Hop Beaujon, Assistance Publ Hop Paris, Paris, France
[8] Ctr Rech Claude Bernard Hepatites Virales, INSERM, U773, Clichy, France
[9] Bristol Myers Squibb Co, Braine Lalleud, Belgium
[10] Bristol Myers Squibb Co, Paris, France
[11] Wroclaw Univ Med, Div Infect Dis & Hepatol, Wroclaw, Poland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1044
引用
收藏
页码:711A / 712A
页数:2
相关论文
共 50 条
  • [31] Outcomes of Entecavir (Etv) and Tenofovir (Tdf) combination therapy in chronic hep-B patients with previous treatment failure
    Gill, M.
    Mehmood, N.
    Salman, F.
    Anwar, N.
    Gill, U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 164 - 165
  • [32] OUTCOMES OF ENTECAVIR (ETV) AND TENOFOVIR (TDF) COMBINATION THERAPY IN CHRONIC HEP-B PATIENTS WITH PREVIOUS TREATMENT FAILURE
    Gill, M.
    Gill, U.
    Anwar, N.
    Salman, F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S201 - S201
  • [33] An evaluation of entecavir treatment among nucleos(t) ide-naive Moroccan patients with chronic hepatitis B
    Chakkor, Amal
    Rouibaa, Fedoua
    Elaboudi, Safiaa
    Aourarh, Aziz
    BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01):
  • [34] Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
    Ibragimov, E. K.
    Abdurakhmanov, D. T.
    Rozina, T. P.
    Nikulkina, E. N.
    Tanaschuk, E. L.
    Odintsov, A., V
    Panevkina, S., V
    Moiseev, S., V
    TERAPEVTICHESKII ARKHIV, 2019, 91 (02) : 40 - 47
  • [35] ANTIVIRAL EFFECT OF ENTECAVIR IN NUCLEOS(T)IDE-EXPERIENCED CHRONIC HEPATITIS B PATIENTS
    Kim, Kyung-ah
    Kim, Jong Yeon
    Lee, June Sung
    HEPATOLOGY, 2011, 54 : 1065A - 1065A
  • [36] Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naive Chronic Hepatitis B Patients in Real Life
    Luo, Jie
    Li, Xiangyong
    Wu, Yuankai
    Lin, Guoli
    Pang, Yihua
    Zhang, Xiao
    Ao, Yunlong
    Du, Zhan
    Zhao, Zhixin
    Chong, Yutian
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (04): : 427 - 433
  • [37] A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
    Kayaaslan, Bircan
    Akinci, Esragul
    Ari, Alpay
    Tufan, Zeliha Kocak
    Alpat, Saygin Nayman
    Gunal, Ozgur
    Tosun, Selma
    Guner, Rahmet
    Tabak, Fehmi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (01) : 40 - 47
  • [38] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
    Huang, Mingxing
    Jie, Yusheng
    Lin, Guoli
    Shi, Hong
    Li, Xinhua
    Li, Xiangyong
    Wu, Yuankai
    Chong, Yutian
    CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 471 - 478
  • [39] Antiviral efficacy of entecavir in nucleos(t)ide-naive patients of Black/African descent with chronic hepatitis B
    Jeffers, L.
    Van Rensburg, C. J.
    Banks, A.
    Schechter, M.
    Schmidt, S. J.
    Hu, W.
    Llamoso, C.
    Parana, R.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (01) : 74 - 76
  • [40] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
    Mingxing Huang
    Yusheng Jie
    Guoli Lin
    Hong Shi
    Xinhua Li
    Xiangyong Li
    Yuankai Wu
    Yutian Chong
    Clinical Drug Investigation, 2016, 36 : 471 - 478